These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6383611)

  • 1. Overview of patient compliance with medication dosing: a literature review.
    Greenberg RN
    Clin Ther; 1984; 6(5):592-9. PubMed ID: 6383611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.
    de Klerk E; van der Heijde D; Landewé R; van der Tempel H; Urquhart J; van der Linden S
    J Rheumatol; 2003 Jan; 30(1):44-54. PubMed ID: 12508389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among physicians and patients.
    Gallant JE; Block DS
    J Int Assoc Physicians AIDS Care; 1998 May; 4(5):32-5. PubMed ID: 11365186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance and compliance-improving strategies in hypertension: the Japanese experience.
    Fujii J; Seki A
    J Hypertens Suppl; 1985 Apr; 3(1):S19-22. PubMed ID: 3870465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term patient compliance with prescribed regimens of calcium channel blockers.
    Farmer KC; Jacobs EW; Phillips CR
    Clin Ther; 1994; 16(2):316-26; discussion 271-2. PubMed ID: 8062325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases.
    Sclar DA; Tartaglione TA; Fine MJ
    Infect Agents Dis; 1994 Oct; 3(5):266-73. PubMed ID: 7866659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of once- and twice-daily dosing regimens on adherence and overall safety.
    Hawkins T
    AIDS Read; 2004 Jun; 14(6):320-2, 324, 329-31, 334-6. PubMed ID: 15243968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
    Cramer JA; Amonkar MM; Hebborn A; Altman R
    Curr Med Res Opin; 2005 Sep; 21(9):1453-60. PubMed ID: 16197664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication compliance among Tanzanian hypertensives.
    Maro EE; Lwakatare J
    East Afr Med J; 1997 Sep; 74(9):539-42. PubMed ID: 9487426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introducing medical students to medication noncompliance.
    Kastrissios H; Flowers NT; Blaschke TF
    Clin Pharmacol Ther; 1996 May; 59(5):577-82. PubMed ID: 8646829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of patients' compliance with prescribed oral and inhaled asthma medications.
    Kelloway JS; Wyatt RA; Adlis SA
    Arch Intern Med; 1994 Jun; 154(12):1349-52. PubMed ID: 8002686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial.
    Kardas P
    J Antimicrob Chemother; 2007 Mar; 59(3):531-6. PubMed ID: 17289766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a randomized crossover study comparing once-daily and thrice-daily sevelamer dosing.
    Fischer D; Cline K; Plone MA; Dillon M; Burke SK; Blair AT
    Am J Kidney Dis; 2006 Sep; 48(3):437-44. PubMed ID: 16931217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation.
    Loghman-Adham M
    Am J Manag Care; 2003 Feb; 9(2):155-71. PubMed ID: 12597603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance-oriented prescribing: simplifying drug regimens.
    Fischer RG
    J Fam Pract; 1980 Mar; 10(3):427-35. PubMed ID: 6986449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence.
    Cramer JA
    Am J Manag Care; 1998 Nov; 4(11):1563-8. PubMed ID: 10338902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.
    Schnitzer T; Bone HG; Crepaldi G; Adami S; McClung M; Kiel D; Felsenberg D; Recker RR; Tonino RP; Roux C; Pinchera A; Foldes AJ; Greenspan SL; Levine MA; Emkey R; Santora AC; Kaur A; Thompson DE; Yates J; Orloff JJ
    Aging (Milano); 2000 Feb; 12(1):1-12. PubMed ID: 10746426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.